Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer


You May Also Like

Solera Health Appoints Dr. Scott Breidbart as Chief Medical Officer

PHOENIX, AZ--(Marketwired - Oct 17, 2016) -  Solera Health, an integrator of chronic disease ...

XBiotech Announces New Patents for Third Quarter 2018

Patents Granted/Allowed for Company’s Candidate Treatments for Cardiovascular Disease, Staphylococcus Aureus Infections and its ...